Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Kovacs Foundation |
---|---|
Information provided by: | Kovacs Foundation |
ClinicalTrials.gov Identifier: | NCT00735735 |
The purpose of this study is to compare the levels of Substance P in saliva, in patients with severe chronic low back pain and in subjects without it. In addition, to explore a possible cutoff point, in order to define normal and pathological levels of Substance P in saliva. The ultimate objective would be to design a measurement method for use in routine clinical practice.
Condition | Intervention |
---|---|
Low Back Pain |
Other: The taking of a saliva sample from each subject. |
Study Type: | Interventional |
Study Design: | Diagnostic, Single Blind (Investigator), Historical Control, Parallel Assignment |
Official Title: | Study of the Measurement of Substance P in the Saliva of Patients With Low Back Pain |
Estimated Enrollment: | 40 |
Study Start Date: | February 2009 |
Estimated Study Completion Date: | October 2009 |
Estimated Primary Completion Date: | October 2009 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
For healthy subjects:
Exclusion Criteria:
Contact: Francisco M Kovacs, MD, PhD | +34 971 720809 | kovacs@kovacs.org |
Contact: María Teresa Gil del Real, MPH | +34 91 3440244 | mtgildelreal@kovacs.org |
Spain, Balearic Islands | |
Kovacs Foundation | Recruiting |
Palma de Mallorca, Balearic Islands, Spain, 07012 | |
Contact: Francisco M Kovacs, MD, PhD +34 971 720809 kovacs@kovacs.org | |
Contact: María Teresa Gil del Real, MPH +34 91 3440244 mtgildelreal@kovacs.org | |
Principal Investigator: Francisco M Kovacs, MD, PhD | |
Sub-Investigator: Mario Gestoso, MD |
Study Director: | Francisco M Kovacs, MD, PhD | Kovacs Foundation, Palma de Mallorca, 07012, Spain |
Principal Investigator: | Mario Gestoso, MD | Kovacs Foundation,Palma de Mallorca, Spain |
Responsible Party: | Kovacs Foundation ( Francisco M. Kovacs, Director of Scientific Department ) |
Study ID Numbers: | FK 26 |
Study First Received: | August 14, 2008 |
Last Updated: | May 27, 2009 |
ClinicalTrials.gov Identifier: | NCT00735735 History of Changes |
Health Authority: | Spain: Comité Ético de Investigación Clínica |
low back pain chronic Substance P |
Signs and Symptoms Neurotransmitter Agents Neurologic Manifestations Low Back Pain |
Pain Back Pain Substance P |
Signs and Symptoms Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Nervous System Diseases Neurologic Manifestations |
Low Back Pain Pain Back Pain Pharmacologic Actions Substance P |